03759 PHARMARON
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.93X | Oper Margin | 15.9% |
|---|---|---|---|
| LT Debt/Equity | 14.3% | Net Margin | 11.8% |
| Total Debt/Equity | 46.7% | Return on Equity | 11.1% |
| Price/Book | 1.93X | Return on Assets | 6.1% |
| (HKD 18.110) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 1,852.09 | 1,907.23 | 1,764.73 | 1,540.64 | 2,031.20 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -2.9 | +8.1 | +14.5 | -24.2 | +46.1 |
| Earnings Per Share (HKD) | 1.051 | 1.078 | 0.996 | 0.869 | 1.141 |
| Earnings Per Share Growth (%) | -2.5 | +8.2 | +14.6 | -23.8 | +45.9 |
| Dividend Per Share (HKD) | 0.223 | 0.219 | 0.220 | 0.219 | 0.235 |
| P/E* (X) | 17.40 | 16.97 | 18.37 | 21.05 | 16.03 |
| Yield (%) | 1.22 | 1.20 | 1.20 | 1.20 | 1.28 |
| Dividend Share (%) | 21.18 | 20.30 | 22.08 | 25.22 | 20.58 |
| Book NAV (HKD) | 9.468 | 8.178 | 7.746 | 6.620 | 6.934 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-05-19 21:00:20
Latest Result
| (RMBMn) | 2026-03 | 2025-03 | Chg* (%) | 2024-03 |
| Cover Period (mths) | 3 | 3 | NA | 3 |
|---|---|---|---|---|
| Turnover | 3,578 | 3,099 | +15.5 | 2,671 |
| Operating Result | 398.543 | 386.384 | +3.1 | 281.103 |
| Associates | 14.216 | -22.797 | -162.4 | -12.484 |
| Profit Before Taxation | 412.759 | 363.587 | +13.5 | 268.619 |
| Taxation | 102.349 | 83.932 | +21.9 | 52.699 |
| Profit /( Loss) After Taxation | 310.41 | 279.655 | +11.0 | 215.92 |
| Minority Interests | -24.949 | -25.92 | -3.7 | -14.638 |
| Net Profit | 335.359 | 305.575 | +9.7 | 230.558 |
| Earnings Per Share () | 0.2111 | 0.1862 | +13.4 | 0.1408 |
| Announcement Date | 2026-04-28 | 2025-04-27 | NA | 2024-04-25 |
* Annualised
Last Update Time: 2026-05-19 21:00:26
